117 related articles for article (PubMed ID: 7940496)
1. Both class I and class II HLA antigens are thyroid cancer susceptibility factors.
Rigopoulou D; Martinez-Laso J; Martinez-Tello F; Alcaide JF; Benmamar D; Hawkins F; Arnaiz-Villena A
Tissue Antigens; 1994 May; 43(5):281-5. PubMed ID: 7940496
[TBL] [Abstract][Full Text] [Related]
2. HLA-class 1 and class 2 antigens in Turkish patients with pemphigus.
Birol A; Anadolu RY; Tutkak H; Gürgey E
Int J Dermatol; 2002 Feb; 41(2):79-83. PubMed ID: 11982641
[TBL] [Abstract][Full Text] [Related]
3. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
4. Weak or absent evidence for the association of HLA-DR antigens with risk of thyroid carcinoma: a meta-analysis of observational studies.
Kamdi AS; Kandavalli NB; Emusu D; Jain N; Mamtani M; Porterfield JR
Tissue Antigens; 2011 Nov; 78(5):382-9. PubMed ID: 21812765
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women.
Hernández-Hernández DM; Cerda-Flores RM; Juárez-Cedillo T; Granados-Arriola J; Vargas-Alarcón G; Apresa-García T; Alvarado-Cabrero I; García-Carrancá A; Salcedo-Vargas M; Mohar-Betancourt A
Int J Gynecol Cancer; 2009 Aug; 19(6):1099-106. PubMed ID: 19820376
[TBL] [Abstract][Full Text] [Related]
6. Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody.
Lloyd RV; Johnson TL; Blaivas M; Sisson JC; Wilson BS
Am J Pathol; 1985 Jul; 120(1):106-11. PubMed ID: 3893150
[TBL] [Abstract][Full Text] [Related]
7. Association of differentiated thyroid carcinoma with HLA-DR7.
Sridama V; Hara Y; Fauchet R; DeGroot LJ
Cancer; 1985 Sep; 56(5):1086-8. PubMed ID: 3874685
[TBL] [Abstract][Full Text] [Related]
8. HLA-DRB1 first domain sequences of two new DR11 alleles and one novel DR4 allele.
Smith AG; Petersdorf EW; Mickelson E; Guthrie LA; Regen L; Martin PJ; Hansen JA
Tissue Antigens; 1993 Nov; 42(5):533-5. PubMed ID: 8146864
[No Abstract] [Full Text] [Related]
9. Differential expression of HLA class II genes associated with disease susceptibility and progression in rheumatoid arthritis.
Heldt C; Listing J; Sözeri O; Bläsing F; Frischbutter S; Müller B
Arthritis Rheum; 2003 Oct; 48(10):2779-87. PubMed ID: 14558083
[TBL] [Abstract][Full Text] [Related]
10. Strong association between an HLA-DR antigen and thyroid carcinoma.
Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
[TBL] [Abstract][Full Text] [Related]
11. Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo.
Hojyo-Tomoka T; Granados J; Vargas-Alarcón G; Yamamoto-Furusho JK; Vega-Memije E; Cortés-Franco R; Flores O; Teixeira F; Domínguez-Soto L
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):935-7. PubMed ID: 9204058
[TBL] [Abstract][Full Text] [Related]
12. [HLA and thyroid cancer].
Dralle H; Robin-Winn M; Reilmann L; Laue A; Török M
Klin Wochenschr; 1986 Jun; 64(11):522-5. PubMed ID: 3459939
[TBL] [Abstract][Full Text] [Related]
13. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
14. Histocompatibility profile of selected Latin American countries.
Santiago-Delpín EA
Transplant Proc; 1991 Apr; 23(2):1861-4. PubMed ID: 2053180
[No Abstract] [Full Text] [Related]
15. HLA class II antigen associations help to define two types of alopecia areata.
Colombe BW; Price VH; Khoury EL; Garovoy MR; Lou CD
J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):757-64. PubMed ID: 7593774
[TBL] [Abstract][Full Text] [Related]
16. The relation of susceptibility to and biologic behavior of thyroid epithelial cell cancer to HLA-DR1.
Juhasz F; Balázs G; Stenszky V; Kozma L; Farid NR
Cancer; 1986 Jul; 58(1):52-4. PubMed ID: 3486708
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigens -A, -B, -C, and -DR and nasopharyngeal carcinoma in northern China.
Zhu XN; Chen R; Kong FH; Liu W
Ann Otol Rhinol Laryngol; 1990 Apr; 99(4 Pt 1):286-7. PubMed ID: 2327697
[TBL] [Abstract][Full Text] [Related]
18. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
19. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
20. HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population.
Al-Shammri S; Nelson RF; Al-Muzairi I; Akanji AO
Mult Scler; 2004 Aug; 10(4):381-6. PubMed ID: 15327033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
